Delta Dental of Tennessee Donates More Than 50,000 Toothbrushes to Food Banks Across the State

Helping students start the school year with a healthy smile NASHVILLE, Tenn.–(BUSINESS WIRE)–As students across Tennessee head back to school, Delta Dental of Tennessee (Delta Dental) is working to ensure that thousands of them are equipped with one of the simplest tools for good oral and overall health: a toothbrush. “Oral health is closely tied … [Read more…]

Shriners Children’s Researcher Pioneers New Method for Treating Rheumatoid and Juvenile Arthritis

Research Could Eventually Lead to New Treatment Methods for Cancer or Diabetes ST. LOUIS–(BUSINESS WIRE)–Shriners Children’s researchers have developed a new way to use the body’s natural internal clock to optimize the delivery of medications and increase their effectiveness. Shriners Children’s St. Louis Director of Research Dr. Farshid Guilak recently published findings on a revolutionary … [Read more…]

Travere Therapeutics Presents Abstracts at the 15th International Congress of Inborn Errors of Metabolism

Presentation details long-term safety and efficacy data on pegtibatinase as a potential treatment for classical HCU SAN DIEGO–(BUSINESS WIRE)–$TVTX #ICIEM2025–Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the Company shared two oral presentations in classical homocystinuria (HCU) at the International Congress of Inborn Errors of Metabolism, taking place September 2-6 in Kyoto, Japan. New long-term … [Read more…]

Medable Launches The Industry’s First Agentic AI Platform and CRA Agent; Removes Bottlenecks in Clinical Development

Agent Studio marks a turning point in clinical research, moving from human-heavy processes to scalable agents that streamline work and accelerate trials PALO ALTO, Calif.–(BUSINESS WIRE)–Medable, the leading technology provider for clinical development, today launched Agent Studio: the industry’s first agentic AI platform purpose-built for life sciences. Agent Studio is a no-code agent-builder that enables … [Read more…]

Dynamic Growth Leads C2N Diagnostics to Expand St. Louis Headquarters to Meet Global Need for Answers to Alzheimer’s Disease

ST. LOUIS–(BUSINESS WIRE)–#Alzheimers—C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, is proud to announce that its early achievements while based in St. Louis are allowing it to triple the size of its operations in its hometown. C2N, a leader in advanced brain health diagnostics, will relocate its … [Read more…]

Hale Farm Selects Elevated Signals to Streamline Operations and Support Growth in Australia’s Evolving Cannabis Market

Tasmanian cultivator adopts Elevated Signals’ manufacturing software to replace manual processes, strengthen compliance, and prepare for future expansion. LAUNCESTON, Australia–(BUSINESS WIRE)–#ERP—Elevated Signals Inc., a leading provider of manufacturing software for cannabis producers, today announced that Hale Farm, a vertically integrated cannabis cultivator and processor based in Tasmania, Australia, has selected its platform to manage production, … [Read more…]

Bruker Announces Public Offering of $600 Million of Mandatory Convertible Preferred Stock

BILLERICA, Mass.–(BUSINESS WIRE)–$BRKR #BRKR—Bruker Corporation (“Bruker”) (Nasdaq: BRKR) today announced it has commenced a public offering, subject to market and other conditions, of $600.0 million of Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share (the “Mandatory Convertible Preferred Stock”). Bruker expects to grant the underwriters a 30-day option to purchase up to … [Read more…]

MEDIPAL HOLDINGS and JCR Pharmaceuticals Sign Global Licensing and Japan Co-Development Agreement for JR-479, a Novel Therapy for GM2 Gangliosidosis

TOKYO & HYOGO, Japan–(BUSINESS WIRE)–MEDIPAL HOLDINGS CORPORATION (TSE 7459, MEDIPAL) and JCR Pharmaceuticals Co., Ltd. (TSE 4552, JCR) announced that the two companies have signed an exclusive global licensing deal and a co-development and commercialization partnership in Japan for JR-479, an investigational therapy for GM2 gangliosidosis, an ultra-rare lysosomal storage disorder. GM2 gangliosidoses are a … [Read more…]

Atria Health Makes Key Hires to Build Out Management Team

NEW YORK–(BUSINESS WIRE)–Atria Health, a value-based provider of technology and administrative support services to cardiovascular care physicians, announced today that it has made several key hires to build out its management team as the company continues its growth trajectory and enters new markets. These hires included Campbell Harlan as Chief Financial Officer, Kaitlyn Lantry as … [Read more…]

Encoded Therapeutics Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for ETX101 in SCN1A+ Dravet Syndrome

Designation based on preliminary clinical evidence indicating the potential for ETX101 to address unmet medical needs associated with SCN1A+ Dravet syndrome Completion of enrollment in POLARIS dose-escalation clinical studies and interim clinical efficacy data presentation planned for 4Q25 State-of-the art internal GMP facility now fully operational to support clinical and future commercial production for ETX101 … [Read more…]